Skip to content
2000
Volume 2, Issue 1
  • ISSN: 2666-7797
  • E-ISSN: 2666-7800

Abstract

Aims

The aim of this study was to evaluate the brightening effects of a complex composed of Resorcinol, Arbutin, and Licorice root extract (RAL complex) in patients faced with skin spots compared to a potential hydroquinone compound.

Background

Skin spots are defined as excessive accumulation of melanin pigment in different layers of the skin caused by extravagant sun exposure, pregnancy, and other hormonal and genetic factors. Therefore, it is necessary to use appropriate products to treat these types of spots.

Objective

To evaluate skin brightness after using the RAL complex, this study was designed in a double-blind randomized trial and the removal of melanin pigment and skin spots was evaluated by different methods.

Methods

In this study, the brightening cream formulated with actives comprising the RAL complex in 2.1% w/w concentration and a hydroquinone cream was applied in two groups of 20 women with a mean age of 48 years showing the severity scale 3 of skin pigmentation, separately. This study was conducted to evaluate the brightening effect of this complex compared to a hydroquinone compound after 4, 8, and, 12 weeks of application to the entire face.

Results

The results showed the highest percentage of skin brightness 12 weeks after applying the cream, reported at 93% and 89% for RAL complex and hydroquinone compound, respectively. Skin pigmentation rate was measured before and after applying the RAL complex cream with a mexameter device. The highest amount of dark spot removal was seen after using this cream in different areas of the skin.

Conclusion

The results showed that the RAL complex was more effective than the hydroquinone compound in removing skin blemishes without any side effects compared to products containing hydroquinone.

Loading

Article metrics loading...

/content/journals/cosci/10.2174/2666779702666230731161153
2023-09-12
2025-01-01
Loading full text...

Full text loading...

References

  1. Braun-FalcoO. PlewigG. WolffH.H. BurgdorfW.H. Braun-FalcoO. PlewigG. WolffH.H. BurgdorfW.H. Disorders of melanin pigmentation.Dermatology200010131042
    [Google Scholar]
  2. BurgerP. LandreauA. AzoulayS. MichelT. FernandezX. Skin whitening cosmetics: Feedback and challenges in the development of natural skin lighteners.Cosmetics2016343610.3390/cosmetics3040036
    [Google Scholar]
  3. EbanksJ. WickettR. BoissyR. Mechanisms regulating skin pigmentation: The rise and fall of complexion coloration.Int. J. Mol. Sci.20091094066408710.3390/ijms10094066 19865532
    [Google Scholar]
  4. CharooN.A. Hyperpigmentation: Looking beyond hydroquinone.J. Cosmet. Dermatol.202221104133414510.1111/jocd.14746 35020267
    [Google Scholar]
  5. WesterhofW. KooyersT.J. Hydroquinone and its analogues in dermatology - a potential health risk.J. Cosmet. Dermatol.200542555910.1111/j.1473‑2165.2005.40202.x 17166200
    [Google Scholar]
  6. ShinJ.W. ParkK.C. Current clinical use of depigmenting agents.Zhonghua Pifuke Yixue Zazhi201432420521010.1016/j.dsi.2014.07.003
    [Google Scholar]
  7. GoldM.H. BironJ. Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma.J. Cosmet. Dermatol.201110318919610.1111/j.1473‑2165.2011.00573.x 21896130
    [Google Scholar]
  8. HerndonJ.H.Jr MakinoE.T. StephensT.J. MehtaR.C. Hydroquinone-free skin brightener system for the treatment of moderate-to-severe facial hyperpigmentation.J. Clin. Aesthet. Dermatol.2014752731 24847406
    [Google Scholar]
  9. BossartS. RameletA.A. WillenbergT. CazzanigaS. BaumgartnerM. HeidemeyerK. HungerR.E. Seyed JafariS.M. Skin hyperpigmentation index facilitating quantification of hyperpigmentation in clinical practice.Dermatology2021237348648810.1159/000509160 32781447
    [Google Scholar]
  10. MatiasA.R. FerreiraM. CostaP. NetoP. Skin colour, skin redness and melanin biometric measurements: comparison study between antera ® 3d, mexameter ® and colorimeter ®.Skin Res. Technol.201521334636210.1111/srt.12199 25645051
    [Google Scholar]
  11. RanuH. ThngS. GohB.K. BurgerA. GohC.L. Periorbital hyperpigmentation in Asians: An epidemiologic study and a proposed classification.Dermatol. Surg.20113791297130310.1111/j.1524‑4725.2011.02065.x 21682796
    [Google Scholar]
  12. KaliternaD. KristinaZ. KovacevicI. Melasma-review of current treatment modalities and efficacy assessment of a new resorcinol-based topical formulation.J Clin Cosmet Dermatol.2017325762826
    [Google Scholar]
  13. KolbeL. MannT. GerwatW. BatzerJ. AhlheitS. SchernerC. WenckH. StäbF. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.J. Eur. Acad. Dermatol. Venereol.201327Suppl. 1192310.1111/jdv.12051 23205541
    [Google Scholar]
  14. BarelA.O. PayeM. MaibachH.I. Eds.; Handbook of cosmetic science and technology.CRC press201410.1201/b16716
    [Google Scholar]
  15. KöpkeD. MüllerR.H. PyoS.M. Phenylethyl resorcinol smartLipids for skin brightening – Increased loading & chemical stability.Eur. J. Pharm. Sci.201913710499210.1016/j.ejps.2019.104992 31302211
    [Google Scholar]
  16. Nieuweboer-KrobotovaL. Hyperpigmentation: Types, diagnostics and targeted treatment options.J. Eur. Acad. Dermatol. Venereol.201327Suppl. 12410.1111/jdv.12048 23205538
    [Google Scholar]
  17. LimY.J. LeeE.H. KangT.H. HaS.K. OhM.S. KimS.M. YoonT.J. KangC. ParkJ.H. KimS.Y. Inhibitory effects of arbutin on melanin biosynthesis of α-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.Arch. Pharm. Res.200932336737310.1007/s12272‑009‑1309‑8 19387580
    [Google Scholar]
  18. BooY.C. Arbutin as a skin depigmenting agent with antimelanogenic and antioxidant properties.Antioxidants2021107112910.3390/antiox10071129 34356362
    [Google Scholar]
  19. CouteauC. CoiffardL. Overview of skin whitening agents: Drugs and cosmetic products.Cosmetics2016332710.3390/cosmetics3030027
    [Google Scholar]
  20. HaddadA.L. MatosL.F. BrunsteinF. FerreiraL.M. SilvaA. CostaD.Jr A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma.Int. J. Dermatol.200342215315610.1046/j.1365‑4362.2003.01621.x 12709008
    [Google Scholar]
  21. CiganovićP. JakimiukK. TomczykM. Zovko KončićM. Glycerolic licorice extracts as active cosmeceutical ingredients: Extraction optimization, chemical characterization, and biological activity.Antioxidants201981044510.3390/antiox8100445 31581512
    [Google Scholar]
  22. AmerM. MetwalliM. Topical hydroquinone in the treatment of some hyperpigmentary disorders.Int. J. Dermatol.199837644945010.1046/j.1365‑4362.1998.00499.x 9646135
    [Google Scholar]
  23. OwolabiJ.O. FabiyiO.S. AdelakinL.A. EkwerikeM.C. Effects of skin lightening cream agents–hydroquinone and kojic acid, on the skin of adult female experimental rats.Clin. Cosmet. Investig. Dermatol.20201328328910.2147/CCID.S233185 32308462
    [Google Scholar]
  24. VinardellM.P. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the scientific committee on consumer safety (SCCS).Regul. Toxicol. Pharmacol.201571219820410.1016/j.yrtph.2014.12.018 25555996
    [Google Scholar]
  25. ErtamI. MutluB. UnalI. AlperS. KivçakB. OzerO. Efficiency of ellagic acid and arbutin in melasma: A randomized, prospective, open-label study.J. Dermatol.200835957057410.1111/j.1346‑8138.2008.00522.x 18837701
    [Google Scholar]
/content/journals/cosci/10.2174/2666779702666230731161153
Loading
/content/journals/cosci/10.2174/2666779702666230731161153
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test